{"id":"76e1b1bd-121f-522b-8423-7fb8a901efb4","stable_key":"56f1d914-e7da-595a-af69-c217b2b47407:l-phenylalanine-pagln-adrenergic","predicate":"signals_with_adrenergic_receptor_dependence","statement":"Knockdown and overexpression experiments implicated ADRA2A, ADRA2B and ADRB2 in PAGln-associated signaling, supporting an adrenergic-receptor-dependent route.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"d6a735a0-0c12-5475-a2ed-2aa1b8e81bb7","mechanism_event_label":"The platelet-related signal connects to receptors used by other physiological pathways.","subject":{"id":"8968a92b-40e9-56fe-8d76-d8776750dbd6","slug":"phenylacetylglutamine","display_name":"Phenylacetylglutamine / PAGln","entity_type_key":"small_molecule"},"object":{"id":"dee4f3e7-443f-5735-84ab-ef92a5787959","slug":"pagln-adrenergic-signaling","display_name":"PAGln adrenergic-receptor-associated signaling","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"d6a735a0-0c12-5475-a2ed-2aa1b8e81bb7","stable_key":"56f1d914-e7da-595a-af69-c217b2b47407:l-phenylalanine-pagln-adrenergic-event","event_type":"observed_relationship","label":"The platelet-related signal connects to receptors used by other physiological pathways.","description":"Knockdown and overexpression experiments implicated ADRA2A, ADRA2B and ADRB2 in PAGln-associated signaling, supporting an adrenergic-receptor-dependent route.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"8968a92b-40e9-56fe-8d76-d8776750dbd6","slug":"phenylacetylglutamine","display_name":"Phenylacetylglutamine / PAGln","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"dee4f3e7-443f-5735-84ab-ef92a5787959","slug":"pagln-adrenergic-signaling","display_name":"PAGln adrenergic-receptor-associated signaling","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"190407ad-0219-54b5-b05f-7c75f3895ca6","slug":"l-phenylalanine","display_name":"L-Phenylalanine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"3aeee4b4-0a31-5c52-88e5-6b112fa5d8b2","slug":"adra2a","display_name":"Human alpha-2A adrenergic receptor / ADRA2A","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"47dfde72-b3e4-514a-a478-c670b19bdaa2","slug":"adra2b","display_name":"Human alpha-2B adrenergic receptor / ADRA2B","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"9f8b3353-a091-5a8e-ba79-42a8c087e877","slug":"adrb2","display_name":"Human beta-2 adrenergic receptor / ADRB2","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"evidence_access","value_text":"Primary full text","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human MEG-01 receptor knockdown and HEK293 receptor-expression experiments, with pharmacologic comparisons.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Functional dependence is not proof of a single orthosteric binding mode or a clinical drug interaction.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"l-phenylalanine","display_name":"L-Phenylalanine","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"The platelet-related signal connects to receptors used by other physiological pathways.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32142679/ · DOI 10.1016/j.cell.2020.02.016","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"1f2d29eb-386c-5fb9-b3f6-7e5b74aeaef9","evidence_kind":"source_excerpt","locator":"Lines 382-388","start_line":382,"end_line":388,"excerpt":"## l-phenylalanine-pagln-adrenergic\nThe platelet-related signal connects to receptors used by other physiological pathways.\nKnockdown and overexpression experiments implicated ADRA2A, ADRA2B and ADRB2 in PAGln-associated signaling, supporting an adrenergic-receptor-dependent route.\nModel: Human MEG-01 receptor knockdown and HEK293 receptor-expression experiments, with pharmacologic comparisons.\nLimitations: Functional dependence is not proof of a single orthosteric binding mode or a clinical drug interaction.\nEvidence access: Primary full text\nA Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32142679/ · DOI 10.1016/j.cell.2020.02.016","model_system":"Human MEG-01 receptor knockdown and HEK293 receptor-expression experiments, with pharmacologic comparisons.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"54de7c56-1e60-5d7b-8ef9-852c58ae92ba","stable_key":"import-56f1d914-e7da-595a-af69-c217b2b47407","title":"L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"4d53adcd4acc7a9aecf44ccb2623ec540c9d221a0f7c00002585870b39b8ffb8","revision_id":"fd182a81-4ab7-559a-9c77-fb4cf72982ef","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}